{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:37Z","timestamp":1792787917895,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860281"],"award-info":[{"award-number":["81860281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Top Experts training Project for the Academy and Technology in Kunming City and Yunnan province","award":["202105AC160030"],"award-info":[{"award-number":["202105AC160030"]}]},{"name":"Yunnan health training project of high level talents","award":["D-2017054"],"award-info":[{"award-number":["D-2017054"]}]},{"name":"Research project of Health Commission of Yunnan Province","award":["2018NS234"],"award-info":[{"award-number":["2018NS234"]}]},{"name":"Research project of Yunnan Clinical Medical Center","award":["2020LCZXKF -XY10"],"award-info":[{"award-number":["2020LCZXKF -XY10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchopulmonary dysplasia (BPD) is one of the most common adverse consequence of premature delivery and the most common chronic lung disease in infants. BPD is associated with long-term lung diseases and neurodevelopmental disorders that can persist into the adulthood. The adverse consequences caused by severe BPD are more serious. However, there were few studies on the risk factors for severe BPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective study of preterm infants born less than 32-week gestational age (GA) and diagnosed with BPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 250 preterm infants with a diagnosis of BPD and GA\u2009&lt;\u200932\u2009weeks were included (137 boys [54.8%] and 113 girls [45.2%]). The birth weight ranged from 700\u2009g to 2010\u2009g and the mean birth weight was 1318.52\u2009g (255.45\u2009g). The GA ranged from 25\u2009weeks to 31\u2009weeks and 6\u2009days (mean, 30\u2009weeks). The number of cases of mild, moderate and severe BPD were 39 (15.6%), 185 (74.0%) and 26 (10.4%), respectively. There were significant differences in the rate of small for gestational age (SGA), intrauterine asphyxia, pulmonary hemorrhage, neonatal respiratory distress syndrome (NRDS), circulatory failure, pulmonary hypertension, patent ductus arteriosus (PDA), pulmonary surfactant (PS), aminophylline, caffeine, glucocorticoids, tracheal intubation, diuretics, and parenteral nutrition length among the three groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The time of parenteral nutrition (aOR\u2009=\u20093.343, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 2.198\u2009~\u20095.085) and PDA (aOR =9.441, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.186\u2009~\u200975.128) were independent risk factors for severe BPD compared with mild BPD. PDA (aOR\u2009=\u20095.202, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.803\u2009~\u200915.010) and aminophylline (aOR\u2009=\u20096.179, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 2.200\u2009~\u200917.353) were independent risk factors for severe BPD, while caffeine (aOR\u2009=\u20090.260, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.092\u2009~\u20090.736) was the protective factor for severe BPD compared with moderate BPD. The time of parenteral nutrition (aOR\u2009=\u20092.972, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.989\u2009~\u20094.440) and caffeine (aOR\u2009=\u20094.525, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.042\u2009~\u200919.649) were independent risk factors for moderate BPD compared with mild BPD. Caffeine (aOR\u2009=\u20093.850, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.358\u2009~\u200910.916) was the independent risk factor for moderate BPD, while PDA (aOR\u2009=\u20090.192, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.067\u2009~\u20090.555) and aminophylline (aOR\u2009=\u20090.162, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.058\u2009~\u20090.455) were protective factors for moderate BPD compared with severe BPD. The time of parenteral nutrition (aOR\u2009=\u20090.337, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.225\u2009~\u20090.503) and caffeine (aOR\u2009=\u20090.221, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.051\u2009~\u20090.960) were protective factors for mild BPD compared with moderate BPD. The time of parenteral nutrition (aOR\u2009=\u20090.299, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.197\u2009~\u20090.455) and PDA (aOR\u2009=\u20090.106, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.013\u2009~\u20090.843) were protective factors for mild BPD compared with severe BPD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The time of parenteral nutrition is the risk factor of moderate and severe BPD. PDA and aminophylline are risk factors for severe BPD. The role of caffeine in the severity of BPD is uncertain, and SGA is not related to the severity of BPD. Severe or moderate BPD can be avoided by shortening duration of parenteral nutrition, early treatment of PDA, reducing use of aminophylline and rational use of caffeine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Retrospectively registered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-022-03273-7","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T03:02:56Z","timestamp":1649732576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Tingting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"issue":"7","key":"3273_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJM196702162760701","volume":"276","author":"WH Northway","year":"1967","unstructured":"Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357\u201368.","journal-title":"N Engl J Med"},{"issue":"7","key":"3273_CR2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3273_CR3","doi-asserted-by":"publisher","first-page":"e164396","DOI":"10.1001\/jamapediatrics.2016.4396","volume":"171","author":"JD Horbar","year":"2017","unstructured":"Horbar JD, Edwards EM, Greenberg LT, et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr. 2017;171(3):e164396.","journal-title":"JAMA Pediatr"},{"issue":"10","key":"3273_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012. JAMA. 2015;314(10):1039\u201351.","journal-title":"JAMA"},{"issue":"3","key":"3273_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1542\/peds.2009-2959","volume":"126","author":"BJ Stoll","year":"2010","unstructured":"Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443\u201356.","journal-title":"Pediatrics"},{"issue":"43","key":"3273_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.15585\/mmwr.mm6543a1","volume":"65","author":"C Ferr\u00e9","year":"2016","unstructured":"Ferr\u00e9 C, Callaghan W, Olson C, et al. Effects of maternal age and age-specific preterm birth rates on overall preterm birth rates - United States, 2007 and 2014. MMWR Morb Mortal Wkly Rep. 2016;65(43):1181\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"3273_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000455966","volume":"112","author":"F Garc\u00eda-Mu\u00f1oz Rodrigo","year":"2017","unstructured":"Garc\u00eda-Mu\u00f1oz Rodrigo F, Losada Mart\u00ednez A, Elorza Fern\u00e1ndez MD, et al. The burden of respiratory disease in very-low-birth-weight infants: changes in perinatal care and outcomes in a decade in Spain. Neonatology. 2017;112(1):30\u20139.","journal-title":"Neonatology"},{"issue":"5","key":"3273_CR8","first-page":"385","volume":"35","author":"PP Li","year":"2020","unstructured":"Li PP, Zhao W. Definition evolution and epidemiological characteristics of bronchopulmonary dysplasia in premature infants. Chin J Neonatol. 2020;35(5):385\u20138.","journal-title":"Chin J Neonatol"},{"issue":"4","key":"3273_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa1700827","volume":"377","author":"LW Doyle","year":"2017","unstructured":"Doyle LW, Carse E, Adams AM, et al. Ventilation in extremely preterm infants and respiratory function at 8 years. N Engl J Med. 2017;377(4):329\u201337.","journal-title":"N Engl J Med"},{"key":"3273_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1605566","volume":"376","author":"N Younge","year":"2017","unstructured":"Younge N, Goldstein RF, Bann CM, et al. Survival and neurodevelopmental outcomes among periviable infants. N Engl J Med. 2017;376:617\u201328.","journal-title":"N Engl J Med"},{"key":"3273_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpeds.2011.12.038","volume":"161","author":"LC De Jesus","year":"2012","unstructured":"De Jesus LC, Pappas A, Shankaran S, et al. Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants. J Pediatr. 2012;161:70\u20134.","journal-title":"J Pediatr"},{"key":"3273_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/j.semperi.2018.09.013","volume":"42","author":"JLY Cheong","year":"2018","unstructured":"Cheong JLY, Doyle LW. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Semin Perinatol. 2018;42:478\u201384.","journal-title":"Semin Perinatol"},{"key":"3273_CR13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00431-017-3009-6","volume":"176","author":"M \u00c1lvarez-Fuente","year":"2017","unstructured":"\u00c1lvarez-Fuente M, Arruza L, Muro M, et al. The economic impact of prematurity and bronchopulmonary dysplasia. Eur J Pediatr. 2017;176:1587\u201393.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"3273_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/jp.2017.49","volume":"37","author":"W Jackson","year":"2017","unstructured":"Jackson W, Hornik CP, Messina JA, et al. In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. J Perinatol. 2017;37(7):853\u20136.","journal-title":"J Perinatol"},{"issue":"1","key":"3273_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000327891","volume":"101","author":"DH Kim","year":"2012","unstructured":"Kim DH, Kim HS, Choi CW, et al. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology. 2012;101(1):40\u20136.","journal-title":"Neonatology"},{"issue":"5","key":"3273_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ajpath.2019.01.014","volume":"189","author":"S Leary","year":"2019","unstructured":"Leary S, Das P, Ponnalagu D, et al. Genetic strain and sex differences in a hyperoxia-induced mouse model of varying severity of bronchopulmonary dysplasia. Am J Pathol. 2019;189(5):999\u20131014.","journal-title":"Am J Pathol"},{"issue":"3","key":"3273_CR17","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1542\/peds.2008-3249","volume":"124","author":"C Bose","year":"2009","unstructured":"Bose C, van Marter LJ, Laughon M, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics. 2009;124(3):e450\u20138.","journal-title":"Pediatrics"},{"issue":"1","key":"3273_CR18","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1136\/adc.2010.210187","volume":"97","author":"L Hartling","year":"2012","unstructured":"Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2012;97(1):F8\u2013F17.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"3273_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1515\/JPM.2004.051","volume":"32","author":"R Antonucci","year":"2004","unstructured":"Antonucci R, Contu P, Porcella A, et al. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J Perinat Med. 2004;32(3):272\u20137.","journal-title":"J Perinat Med"},{"key":"3273_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.rmed.2017.10.014","volume":"132","author":"R Kalikkot Thekkeveedu","year":"2017","unstructured":"Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170\u20137.","journal-title":"Respir Med"},{"issue":"4","key":"3273_CR21","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1113\/JP276040","volume":"597","author":"A Sehgal","year":"2019","unstructured":"Sehgal A, Gwini SM, Menahem S, et al. Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology. J Physiol. 2019;597(4):1209\u201320.","journal-title":"J Physiol"},{"issue":"8","key":"3273_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00431-017-2957-1","volume":"176","author":"S Nobile","year":"2017","unstructured":"Nobile S, Marchionni P, Carnielli VP. Neonatal outcome of small for gestational age preterm infants. Eur J Pediatr. 2017;176(8):1083\u20138.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"3273_CR23","first-page":"262","volume":"20","author":"WL Li","year":"2018","unstructured":"Li WL, Xu FL, Niu M, et al. Clinical features and prognosis of preterm infants with varying degrees of bronchopulmonary dysplasia. Zhongguo Dang Dai Er Ke Za Zhi. 2018;20(4):262\u20136.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"7","key":"3273_CR24","doi-asserted-by":"publisher","first-page":"e0235901","DOI":"10.1371\/journal.pone.0235901","volume":"15","author":"SH Kim","year":"2020","unstructured":"Kim SH, Han YS, Chun J, et al. Risk factors that affect the degree of bronchopulmonary dysplasia: comparison by severity in the same gestational age. PLoS One. 2020;15(7):e0235901.","journal-title":"PLoS One"},{"issue":"2","key":"3273_CR25","doi-asserted-by":"publisher","first-page":"F192","DOI":"10.1136\/archdischild-2017-314171","volume":"104","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Foglia EE, Dysart KC, et al. Adverse effects of small for gestational age differ by gestational week among very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2019;104(2):F192\u20138.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"3273_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12519-021-00481-6","volume":"18","author":"WW Zhang","year":"2022","unstructured":"Zhang WW, Yu YH, Dong XY, et al. Treatment status of extremely premature infants with gestational age\u2009<\u200928 weeks in a Chinese perinatal center from 2010 to 2019. World J Pediatr. 2022;18(1):67\u201374.","journal-title":"World J Pediatr"},{"issue":"1 Suppl","key":"3273_CR27","doi-asserted-by":"publisher","first-page":"81S","DOI":"10.1177\/0148607111424411","volume":"36","author":"M Rayyan","year":"2012","unstructured":"Rayyan M, Devlieger H, Jochum F, et al. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012;36(1 Suppl):81S\u201394S.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"5","key":"3273_CR28","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00431-020-03912-0","volume":"180","author":"BG Milanesi","year":"2021","unstructured":"Milanesi BG, Lima PA, Villela LD, et al. Assessment of early nutritional intake in preterm infants with bronchopulmonary dysplasia: a cohort study. Eur J Pediatr. 2021;180(5):1423\u201330.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"3273_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/NPM-190267","volume":"13","author":"Y Al-Jebawi","year":"2020","unstructured":"Al-Jebawi Y, Agarwal N, Groh Wargo S, et al. Low caloric intake and high fluid intake during the first week of life are associated with the severity of bronchopulmonary dysplasia in extremely low birth weight infants. J Neonatal Perinatal Med. 2020;13(2):207\u201314.","journal-title":"J Neonatal Perinatal Med"},{"issue":"19","key":"3273_CR30","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1080\/14767058.2017.1347921","volume":"31","author":"P H\u00e4rkin","year":"2018","unstructured":"H\u00e4rkin P, Marttila R, Pokka T, et al. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study. J Matern Fetal Neonatal Med. 2018;31(19):2576\u201383.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3273_CR31","doi-asserted-by":"publisher","first-page":"648372","DOI":"10.3389\/fped.2021.648372","volume":"9","author":"KW Olsson","year":"2021","unstructured":"Olsson KW, Youssef S, Kjellberg M, et al. A matched case control study of surgically and non-surgically treated patent ductus arteriosus in extremely preterm infants. Front Pediatr. 2021;9:648372.","journal-title":"Front Pediatr"},{"issue":"20","key":"3273_CR32","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112\u201321.","journal-title":"N Engl J Med"},{"issue":"19","key":"3273_CR33","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893\u2013902.","journal-title":"N Engl J Med"},{"key":"3273_CR34","doi-asserted-by":"publisher","unstructured":"Henderson-Smart DJ, De Paoli AG. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev. 2010;(12):CD000140. https:\/\/doi.org\/10.1002\/14651858.CD000140.pub2.","DOI":"10.1002\/14651858.CD000140.pub2"},{"issue":"6","key":"3273_CR35","first-page":"501","volume":"8","author":"V Lamba","year":"2021","unstructured":"Lamba V, Winners O, Fort P. Early high-dose caffeine improves respiratory outcomes in preterm infants. Children (Basel). 2021;8(6):501.","journal-title":"Children (Basel)"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03273-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T03:05:48Z","timestamp":1649732748000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03273-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3273"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03273-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1205890\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"26 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics committee of The First People\u2019s Hospital of Yunnan Province (Ethic number: KHLL2021-KY001). Informed consent was waived due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}